Form 8-K - Current report:
SEC Accession No. 0001420720-22-000067
Filing Date
2022-10-14
Accepted
2022-10-14 16:13:58
Documents
13
Period of Report
2022-10-11
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K ibio-20221011x8k.htm   iXBRL 8-K 27000
  Complete submission text file 0001420720-22-000067.txt   146868

Data Files

Seq Description Document Type Size
2 EX-101.SCH ibio-20221011.xsd EX-101.SCH 4011
3 EX-101.DEF ibio-20221011_def.xml EX-101.DEF 3281
4 EX-101.LAB ibio-20221011_lab.xml EX-101.LAB 13580
5 EX-101.PRE ibio-20221011_pre.xml EX-101.PRE 10175
7 EXTRACTED XBRL INSTANCE DOCUMENT ibio-20221011x8k_htm.xml XML 4663
Mailing Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737
Business Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737 302 355-0650
iBio, Inc. (Filer) CIK: 0001420720 (see all company filings)

EIN.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-35023 | Film No.: 221311516
SIC: 2834 Pharmaceutical Preparations